Sara Ferrillo
University of Parma
6 Papers
27 Citations
Sara Ferrillo is an academic researcher from University of Parma. The author has contributed to research in topics: Wnt signaling pathway & Cellular differentiation. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
RhoA Controls Wnt Upregulation on Microstructured Titanium Surfaces
Simone Lumetti,Silvia Mazzotta,Sara Ferrillo,Maddalena Piergianni,Marilina Piemontese,Giovanni Passeri,Guido Maria Macaluso,Carlo Galli +7 more
TL;DR: Data show that RhoA is upregulated in cells on rough surfaces and it affects the activation of Wnt canonical signaling through Myosin II modulation.
•Journal Article
Pharmacological GSK-3beta inhibition improves osteoblast differentiation on titanium surfaces.
Simone Lumetti,Sara Ferrillo,Silvia Mazzotta,Guido Maria Macaluso,Mauro Bonanini,Giovanni Passeri,Carlo Galli +6 more
TL;DR: BIO enhances Wnt signaling activation and the expression of osteoblastic genes on rough surfaces and could be a viable approach to improve cell response to implant surfaces.
6
Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
Vittoria Poli,Luca Fagnocchi,Luca Fagnocchi,Alessandra Fasciani,Alessandro Cherubini,Stefania Mazzoleni,Sara Ferrillo,Annarita Miluzio,Gabriella Gaudioso,Gabriella Gaudioso,Valentina Vaira,Valentina Vaira,Alice Turdo,Miriam Gaggianesi,Aurora Chinnici,Elisa Lipari,Silvio Bicciato,Silvano Bosari,Silvano Bosari,Matilde Todaro,Alessio Zippo,Alessio Zippo +21 more
TL;DR: The affiliation details for Gabriella Gaudioso, Valentina Vaira, and Silvano Bosari incorrectly omitted ‘Division of Pathology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy’.
•Journal Article
Study of GSK3b inhibitors SB415286 and SB216763 to improve osteoblastic differentiation on microstructured titanium.
Simone Lumetti,Elena Calciolari,Ludovica Parisi,Andrea Toffoli,Silvia Mazzotta,Sara Ferrillo,G Ierardo,Guido Maria Macaluso,Carlo Galli,Edoardo Manfredi +9 more
TL;DR: SB216763 and SB415286 inhibitors should be further investigated as potential tools to improve cell differentiation on titanium surfaces for endosseous implants.
2
MYC-driven epigenetic reprogramming favors the onset of tumorigensis by inducing a stem cell-like state
Vittoria Poli,Luca Fagnocchi,Alessandra Fasciani,Alessandro Cherubini,Stefania Mazzoleni,Sara Ferrillo,Annarita Miluzio,Gabriella Gaudioso,Valentina Vaira,Alice Turdo,Miriam Gaggianesi,Aurora Chinnici,Elisa Lipari,Silvio Bicciato,Silvano Bosari,Matilde Todaro,Alessio Zippo +16 more
TL;DR: The notion that MYC-driven tumor initiation relies on cell reprogramming, which is mediated by the activation ofMYC-dependent oncogenic enhancers, is supported, thus establishing a therapeutic rational for treating basal-like breast cancers.